JAMA Internal Medicine, 184 (9), 10561064
Diabetic retinopathy Rapid improvement in glycaemic control, particularly with semaglutide, may temporarily worsen diabetic retinopathy
Also, insurance coverage for these medications is very often limited and recommended for patients with a severe medical necessity
Third, it synchronizes the ipamorelin Cmax window (1530 minutes post-injection) and tesamorelin's GHRH receptor activation (peak within 2040 minutes) with the onset of slow-wave sleep
Of course, with microdosing we would expect less of the gastrointestinal side effects as those effects are dose-dependent, so a lower dose means lower side effects. Many patients interested in microdosing are also interested in short-term GLP-1 drug use, but Dr